George C. Carpenter IV, President and Chief Executive Officer
Mr. Carpenter has been serving as our Chief Executive Officer since April 10, 2009, served as our President from October 1, 2007 until April 10, 2009 and was reappointed our President on April 29, 2011. As President until 2009, Mr. Carpenter’s primary responsibility involved developing strategy and commercializing our rEEG technology. Mr. Carpenter also served as a director from April 2009 until November 2012. From 2002 until he joined CNS in October 2007, Mr. Carpenter was the President and CEO of WorkWell Systems, Inc., a national physical medicine firm that manages occupational health programs for Fortune 500 employers. Prior to his position at WorkWell Systems, Mr. Carpenter founded and served as Chairman and CEO of Core, Inc., a company focused on integrated disability management and work-force analytics. He served in those positions from 1990 until Core was acquired by Assurant, Inc. in 2001. From 1984 to 1990, Mr. Carpenter was a Vice President of Operations with Baxter Healthcare, served as a Director of Business Development and as a strategic partner for Baxter’s alternate site businesses. Mr. Carpenter began his career at Inland Steel where he served as a Senior Systems Consultant in manufacturing process control. Mr. Carpenter holds an MBA in Finance from the University of Chicago and a BA with Distinction in International Policy & Law from Dartmouth College.
Brian MacDonald, Chief Technology Officer
Brian is responsible for the machine learning algorithms that form the core of the PEER report as well as the secure, cloud-based PEER production system that physicians use to submit data to MYnd Analytics for analysis and to retrieve the results. Brian is one of the original co-founders of CNS Response, the predecessor company to MYnd Analytics. He holds a B.S. in Chemical Engineering from the University of Alabama and an MBA from the Wharton School of the University of Pennsylvania.
Donald D'Ambrosio, Chief Financial Officer and Secretary
Donald E. D’Ambrosio was appointed to the position of Chief Financial Officer on March 31, 2017. Prior to joining MYnd Analytics, from 1996 to 2007 Mr. D’Ambrosio served as Senior Vice President, Controller and, ultimately, Chief Financial Officer of BNC Mortgage, Inc. (NASDAQ: BNCM). As BNC’s CFO Mr. D’Ambrosio played a key role in the company’s IPO, raising $35 million, and its listing on the NASDAQ on March 10, 1998 which was underwritten by CIBC Oppenheimer and Piper Jaffray, Inc. Subsequently, Mr. D’Ambrosio was also intimately involved in taking the company private through a $52 million management acquisition by Lehman Brothers. Mr. D’Ambrosio played a key role of BNC Mortgage Inc’s acquisition of certain assets and liabilities and the origination platform of America’s Lender, Inc. From 2007 through to February 2017 Mr. D’Ambrosio founded and built Oxygen Funding, Inc., an asset-based lending company that specialized in providing working capital to small businesses, where he served its President, CEO and CFO. Oxygen Funding grew to fund over $100 million of client receivables. Mr. D’Ambrosio was a featured speaker for the Small Business Association and a writer for the Commercial Factor magazine. Mr. D’Ambrosio holds a Bachelor of Business Administration degree with an emphasis in accounting from Temple University. Mr. D’Ambrosio joins the Company with his skill and experience as a Chief Financial Officer along with his IPO and NASDAQ up-listing experience.
R. Stewart Navarre, Vice President, Government Accounts
Mr. Navarre serves as Vice President, Government Accounts. Since coming on board CNS Response in February 2011, his primary responsibility has centered on account development and adoption of the PEER technology by large institutional and government customers to include the US military and Veterans Health Administration. An essential element of this pursuit has been the creation and execution of the third largest study in mental health treatment in two decades, the PEER Interactive Study, an FDA-approved study currently underway at the US military’s flagship medical treatment facility, the Walter Reed National Military Medical Center in Bethesda, Maryland, and the Fort Belvoir Community Hospital - a major military medical center located in northern Virginia serving the Greater Washington, DC metro area. He is currently on site leading the execution of that study. Prior to joining CNS Response, Mr. Navarre served as an infantry officer with the United States Marine Corps for over 30 years, culminating in command of the 5th Marine Regiment, headquartered at Camp Pendleton, California, and deploying in support of Operation Iraqi Freedom during 2003 - 2005. His final tour on active duty was as Chief of Staff for the Marine Corps bases west of the Mississippi. During his Marine Corps career he served at posts and stations across the country and around the world while assigned at the Pentagon, on the East and West Coasts of our nation as well as Japan, the Middle East, and South America. Colonel Navarre, USMC (Retired), began his career as a midshipman at the United States Naval Academy, graduated with a Bachelor of Science in Biology and Chemistry and was commissioned a second lieutenant of Marines. He holds a MBA from the University of Evansville, Indiana.